Severe cutaneous drug reactions in children

被引:0
|
作者
Mockenhaupt, Maja [1 ,2 ]
机构
[1] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Freiburg, Germany
[2] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Hauptstr 7, D-79104 Freiburg, Germany
关键词
Epidermal necrolysis; Drug reaction with eosinophilia and systemic symptoms; Anticonvulsants; Sulfonamides; Sulfasalazine; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; SYSTEMIC SYMPTOMS; MULTIFORME MAJUS; DRESS; EPIDEMIOLOGY; SCORTEN;
D O I
10.1007/s00112-023-01753-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as "epidermal" or "epithelial necrolysis" (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended.
引用
收藏
页码:439 / 451
页数:13
相关论文
共 50 条
  • [41] Identifying the Culprit Drug in Severe Cutaneous Adverse Reactions (SCARs)
    Rosario Cabañas
    Elena Ramírez
    Teresa Bellón
    Current Treatment Options in Allergy, 2021, 8 : 194 - 209
  • [42] Ethical considerations in the management of drug severe cutaneous adverse reactions
    Buckey, Timothy M.
    Ferreira, Alana L.
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (04) : 964 - 965
  • [43] Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
    Chang, Chih-Jung
    Chen, Chun-Bing
    Hung, Shuen-Iu
    Ji, Chao
    Chung, Wen-Hung
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [44] Drug reexposure in children with severe mucocutaneous reactions
    Moral, Luis
    Toral, Teresa
    Gilabert, Ana
    Sanchez, Ares
    Francisco Silvestre, Juan
    Manuel Marco, Francisco
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2022, 50 (01) : 104 - 107
  • [45] Severe cutaneous reactions caused by barbiturates in seven Iranian children
    Mamishi, Setareh
    Fattahi, Fatemeh
    Pourpak, Zahra
    Aghaee, Farzaneh Mirza
    Moinfar, Zeinab
    Mohammadi, Mahmoud
    Ashrafi, Mahmoud
    Moin, Mostafa
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (11) : 1254 - 1261
  • [46] Variation in Management and Outcomes of Children Hospitalized With Severe Cutaneous Reactions
    Antoon, James W.
    Goldman, Jennifer L.
    Lee, Brian
    PEDIATRICS, 2018, 142
  • [47] Diagnostic methods for severe cutaneous adverse drug reactions by inpatient dermatologists
    Park, Candice
    Kaffenberger, Benjamin H.
    Trinidad, John C. L.
    Korman, Abraham M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (06) : E342 - E344
  • [48] Drug patch testing for severe cutaneous adverse reactions: Not in the United States?
    Whitley, Lori
    Honsinger, Richard
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (05) : 538 - 539
  • [49] Severe and acute drug cutaneous adverse reactions (SCARs): how to prevent?
    Benussi, Cristina C.
    Puma, Alessia
    Lonati, Davide
    Re, Azzurra
    Giarda, Paola
    Mattiuzzo, Elena
    Negrini, Valentina
    Locatelli, Carlo A.
    CLINICAL TOXICOLOGY, 2024, 62 : 71 - 71
  • [50] SEVERE CUTANEOUS DRUG-REACTIONS TO TENOXICAM - A REPORT OF 3 CASES
    CHOSIDOW, O
    LEBRE, C
    ROUJEAU, JC
    REVUZ, J
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1991, 118 (11): : 903 - 904